Odimma Therapeutics participated in BIO-Europe Spring 2023, held in Basel, Switzerland, one of Europe’s leading partnering events for the biotechnology and life sciences industry.
The conference brought together biotechnology companies, pharmaceutical leaders, investors and healthcare innovators from around the world to explore strategic collaborations and emerging opportunities across the sector.
Participation in BIO-Europe Spring supported Odimma Therapeutics’ objective of expanding its international network and strengthening relationships across the precision oncology ecosystem as the company continued advancing its personalized immunotherapy platform.
The event also provided an opportunity to engage with potential partners and investors supporting the future development of ODI-2001 and the broader Odimma platform.
